Clinical trial
Evaluation of the Effectiveness of Pulsed Electromagnetic Field Therapy in Patients With Symptomatic Plantar Calcaneal Spurs: A Prospective, Randomized, Sham-Controlled Trial
NCT07919600 is registered in ClinicalTrials.gov with Hatice Zehra FERHATLAR as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Effectiveness of Pulsed Electromagnetic Field Therapy in Patients With Symptomatic Plantar Calcaneal Spurs: A Prospective, Randomized, Sham-Controlled Trial
- Lead sponsor
- Hatice Zehra FERHATLAR
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 28, 2026
- Completion date
- January 29, 2027
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
calcaneal spur
Arms
As registered; 2 arms.
-
Active PEMF Group
Participants in this group will receive active pulsed electromagnetic field (PEMF) therapy using a BTL-4000 magnetotherapy device with a solenoid applicator. Treatment will be administered at a magnetic field intensity of 2 mT and a frequency of 50 Hz for 20 minutes per session, three times per week for four weeks (12 sessions in total). All participants will also receive a standardized plantar fascia and gastrocnemius-soleus stretching exercise program.
-
Sham PEMF Group
Participants in this group will undergo sham PEMF treatment using the same BTL-4000 magnetotherapy device, solenoid applicator, patient positioning, and session duration as the active treatment group. However, the electromagnetic field output will remain deactivated throughout each session. Sham treatment will be administered for 20 minutes per session, three times per week for four weeks (12 sessions in total). All participants will also receive the same standardized plantar fascia and gastrocnemius-soleus stretching exercise program.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Change in Morning First-Step Pain Intensity Assessed by Visual Analog Scale (VAS)
Morning first-step heel pain intensity will be assessed using a Visual Analog Scale (VAS), with higher scores indicating greater pain intensity. The change from baseline will be compared between the active PEMF and sham PEMF groups at weeks 4, 8, and 12.
Lead sponsor's other trials
Hatice Zehra FERHATLAR, most recent start first.
Similar trials
Same condition (Heel Spur) and phase, most recent start first.
+17 more trials See the condition page